Brominated Vegetable Oil vs Carrageenan: which is worse?

What is Brominated Vegetable Oil?

Brominated vegetable oil (BVO) is a food additive created by bonding bromine atoms to vegetable oil (typically soybean oil), creating a denser-than-water compound. When added to citrus-flavored beverages, BVO acts as an emulsifier and weighting agent, keeping citrus flavor oils evenly distributed throughout the drink rather than floating to the surface.

What is Carrageenan?

Carrageenan is a polysaccharide extracted from red seaweed (primarily Chondrus crispus and Eucheuma species). Used as a thickener, gelling agent, and stabilizer in food and personal care products. Food-grade carrageenan (undegraded) is different from degraded carrageenan (poligeenan), which is not food-grade and is a known inflammatory agent.

Documented risks

Brominated Vegetable Oil: BVO's health concerns center on bromine accumulation in body fat and tissues. Bromine is a halogen related to iodine, and it competes with iodine in the body, potentially disrupting thyroid function—a critical concern since iodine is essential for thyroid hormone synthesis. The FDA-NIH collaborative research directly triggering the 2024 ban found adverse cardiac and thyroid effects in animal studies. This FDA-NIH work, published around 2022–2023, showed effects at dose levels closer to realistic human exposure than previous studies, removing the basis for BVO's safety determination under the Federal Food, Drug, and Cosmetic Act's 'reasonable certainty of no harm' standard. Historical case reports of human toxicity from excessive BVO consumption document bromoderma (skin lesions), memory loss, nerve damage, tremors, and fatigue in individuals consuming large volumes of BVO-containing beverages daily. Two well-documented US cases from the 1970s and 1980s involved bromism (bromine toxicity) from chronic overconsumption. Bromine bioaccumulates in fatty tissues. Long-term sub-clinical accumulation was a concern even before the FDA ban, particularly for heavy consumers of citrus sodas. The EU, Japan, and other countries banned BVO decades ago, making the US one of the last major markets to revoke approval. The FDA issued a proposed rule in November 2023 and a final rule on July 3, 2024, effective August 2, 2024, with compliance deadline August 2, 2025, after which BVO-containing products may not be manufactured for US sale.

Carrageenan: Carrageenan safety has been disputed for decades, centering on the distinction between undegraded (food-grade, high-molecular-weight) carrageenan and degraded carrageenan (poligeenan). Poligeenan, produced by acid hydrolysis, is a known inflammatory and carcinogenic agent in animals. Food-grade carrageenan is a different molecule, but critics argue it can partially degrade in the acidic stomach environment. Dr. Joanne Tobacman at the University of Illinois has published multiple studies on carrageenan-induced inflammation. A 2001 paper in Environmental Health Perspectives (PMC1240867) demonstrated that food-grade carrageenan activates inflammatory signaling pathways (NF-κB) in human intestinal cells, inhibits insulin signaling, and causes intestinal injury in animal models. Her 2012 review in the Journal of Diabetes Research summarized multiple animal studies showing intestinal inflammation, ulcerations, and neoplasms. A 2017 review in Environmental Health Perspectives (Bhide et al.) found carrageenan activated NF-κB inflammatory pathways and could potentially exacerbate inflammatory bowel disease (IBD) in susceptible individuals. Major regulatory bodies including EFSA (comprehensive 2018 re-evaluation) and the WHO/FAO JECFA have consistently concluded that undegraded food-grade carrageenan does not cause cancer or significant harm at typical food use levels in healthy adults. However, the EU precautionary ban in infant formula (2018) acknowledged that infants' developing digestive systems may be more vulnerable to carrageenan's potential effects, and insufficient evidence of safety existed for this specific high-risk population. The USDA's removal of carrageenan from Organic certification (2018) reflected organic industry stakeholder concern despite the continued regulatory permission. Individuals with IBD or gut sensitivity may have reason to avoid carrageenan based on in vitro and animal data, even if the general population safety at food use levels is defended by EFSA and JECFA.